Position:
Clinical Assistant Professor
Division:
Medical Oncology
Research Interests:

Gastrointestinal, genitourinary and early-phase clinical trials in medical oncology.

Education:
B.Sc. McGill University Microbiology & Immunology
M.D.C.M. McGill University
Recent Publications:
  • Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int. 2011 Nov;108(10):1556-63 Epub 2011 Sep 27.
  • Michels J, Ellard SL, Le L, Kollmannsberger C, Murray N, Tomlinson Guns ES, Carr R, Chi KN.  A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer.  Ann Oncol. 2009 Jul 24. [Epub ahead of print].
  • Coppin C, Autenrieth M, Le L, Porzsolt F, and Wilt T.  Targeted Therapy for Advanced Renal Cell Cancer.  Cochrane Database Syst Rev 2008 Apr 16;(2):CD006017.
  • Hotte SJ, Hirte HW, Chen EX, Siu LL, Le LH, Corey A, Iacobucci A, MacLean M, Lo L, Fox NL, Oza AM.  A Phase 1 Study of Mapatumumab (Fully-Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies.  Clin Cancer Res 14: 3450-3455; 2008.
  • Duran, I, J Kortmansky, D Singh, H Hirte, W Kocha, G Goss, L Le, A Oza, T Nicklee, J Ho, D Birle, GR Pond, D Arboine, J Dancey, S Aviel-Ronen, MS Tsao, D Hedley and LL Siu. “A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas”. Br J Cancer. 95: 1148 – 1154; 2006.